CIK 0001160308 · Non-accelerated filer<br>Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841318182
- Phone
- 51285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-24 | Parker Braden C. Chief Commercial Officer | Shares withheld for taxes | −29,323 | $5.07 | $149K | 75,677 |
| 2026-07-15 | Lutz Robert Matthew Chief Fin. & Operating Officer | Grant or award | +35,000 | 328,977 | ||
| 2026-07-15 | Lutz Robert Matthew Chief Fin. & Operating Officer | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-22 | Lowrance David L Chief Financial Officer | Option exercise | +75,000 | $1.59 | $119K | 611,032 |
| 2026-06-22 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −21,682 | $5.50 | $119K | 589,350 |
| 2026-06-22 | Lowrance David L Chief Financial Officer | Option exercise | +129,350 | $1.23 | $159K | 718,700 |
| 2026-06-22 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −28,928 | $5.50 | $159K | 689,772 |
| 2026-06-22 | Lowrance David L Chief Financial Officer | Option exercise | +56,937 | $1.11 | $63K | 746,709 |
| 2026-06-22 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −11,491 | $5.50 | $63K | 735,218 |
| 2026-06-22 | Lowrance David L Chief Financial Officer | Option exercise | +218,750 | $1.51 | $330K | 953,968 |
| 2026-06-22 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −60,057 | $5.50 | $330K | 893,911 |
| 2026-06-22 | Lowrance David L Chief Financial Officer | Option exercise | +12,500 | $4.45 | $56K | 906,411 |
| 2026-06-22 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −10,114 | $5.50 | $56K | 896,297 |
| 2026-06-22 | Lowrance David L Chief Financial Officer | Option exercise | +87,650 | $3.35 | $294K | 983,947 |
| 2026-06-22 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −53,387 | $5.50 | $294K | 930,560 |
| 2026-06-22 | Lowrance David L Chief Financial Officer | Sale | −394,528 | $5.68 | $2.2M | 536,032 |
| 2026-06-22 | Lowrance David L Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −75,000 | 0 | ||
| 2026-06-22 | Lowrance David L Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −129,350 | 0 | ||
| 2026-06-22 | Lowrance David L Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −56,937 | 0 | ||
| 2026-06-22 | Lowrance David L Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −218,750 | 31,250 |
Page 1 of 11 · 202 trades